Molina Healthcare, Inc.(MOH)Earnings, Financials & Key RatiosMolina Healthcare, Inc. (MOH) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's forward P/E of 44.76 appears difficult to justify given the recent 2025Q4 net loss of $160 million and the ongoing instability in core operational margins.
Molina Healthcare, Inc. (MOH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Molina Healthcare, Inc. (MOH) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 22, 2026 | $2.35vs $1.90+23.7% | $10.8Bvs $10.9B-0.7% |
| Q1 2026 | Feb 5, 2026 | $2.75vs $0.43-739.5% | $11.4Bvs $10.9B+4.6% |
| Q4 2025 | Oct 22, 2025 | $1.84vs $3.97-53.7% | $11.5Bvs $11.3B+1.7% |
| Q3 2025 | Jul 23, 2025 | $5.48vs $5.62-2.5% | $11.4Bvs $11.0B+4.3% |
Recent stock market news and headlines for Molina Healthcare, Inc. (MOH)
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Explore how portfolio size and sector exposure differ between these two small-cap ETFs, each offering unique advantages for investors.
Molina (MOH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Joel Greenblatt's Magic Formula ranks stocks on two factors: earnings yield (EBIT divided by enterprise value) and return on capital.
Before Michael Burry shut down Scion Asset Management in late 2025 and pivoted to publishing a Substack newsletter warning of an “AI Bubble,” his final 13F filings reportedly disclosed put options against NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) and Palantir (NASDAQ:PLTR) alongside a heavy rotation, around 51% of the disclosed portfolio, into health insurer Molina Healthcare.
Key metrics vs top competitors for Molina Healthcare, Inc. (MOH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $232.90 | $12.13B | 26.11 | 11.75% | 1.04% | 11.02% | — | |
| $66.12 | $32.65B | -4.85 | 19.44% | -3.25% | -28.6% | — | |
| $24.05 | $4.91B | -6500.00 | 46.06% | 0.47% | 11.5% | — | |
| $428.19 | $388.86B | 32.37 | 11.81% | 2.68% | 11.54% | — | |
| $104.33 | $133.12B | 75.06 | 7.85% | 0.72% | 3.86% | — | |
| $418.85 | $90.96B | 16.67 | 12.62% | 2.62% | 11.92% | — |
Molina Healthcare, Inc. (MOH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Molina Healthcare, Inc. (MOH) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 22, 2026·SEC
Feb 26, 2026·SEC
Feb 6, 2026·SEC
Get notified when MOH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Molina Healthcare, Inc. (MOH) stock FAQ — growth, dividends, profitability & financials explained
Molina Healthcare, Inc. (MOH) reported $45.08B in revenue for fiscal year 2025. This represents a 6897% increase from $644.2M in 2002.
Molina Healthcare, Inc. (MOH) grew revenue by 11.7% over the past year. This is steady growth.
Yes, Molina Healthcare, Inc. (MOH) is profitable, generating $188.0M in net income for fiscal year 2025 (1.0% net margin).
Molina Healthcare, Inc. (MOH) has a return on equity (ROE) of 11.0%. This is reasonable for most industries.
Molina Healthcare, Inc. (MOH) generated $251.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
